vadimezan has been researched along with fluorodeoxyglucose f18 in 1 studies
| Studies (vadimezan) | Trials (vadimezan) | Recent Studies (post-2010) (vadimezan) | Studies (fluorodeoxyglucose f18) | Trials (fluorodeoxyglucose f18) | Recent Studies (post-2010) (fluorodeoxyglucose f18) |
|---|---|---|---|---|---|
| 272 | 16 | 101 | 34,771 | 2,160 | 20,111 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Behe, M; Braun, F; Grosu, AL; Milanović, D; Niedermann, G; Weber, W | 1 |
1 other study(ies) available for vadimezan and fluorodeoxyglucose f18
| Article | Year |
|---|---|
The influence of the combined treatment with Vadimezan (ASA404) and taxol on the growth of U251 glioblastoma xenografts.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Body Weight; Cell Line, Tumor; Female; Fluorodeoxyglucose F18; Glioblastoma; Humans; Mice; Mice, Nude; Paclitaxel; Positron-Emission Tomography; Tumor Burden; Xanthones; Xenograft Model Antitumor Assays | 2012 |